Registry for Upper Gastrointestinal Bleeding
The Orange County Bleeding Consortium (OCBC): Registry of Patients Undergoing Endoscopic Procedures for Upper Gastrointestinal Bleeding in AdventHealth Hospitals in Central Florida
1 other identifier
observational
2,999
1 country
1
Brief Summary
This project aims to evaluate the data on all patients undergoing endoscopic therapy for upper gastrointestinal bleeding.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedFirst Submitted
Initial submission to the registry
October 30, 2019
CompletedFirst Posted
Study publicly available on registry
December 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2021
CompletedFebruary 17, 2022
February 1, 2022
1.3 years
October 30, 2019
February 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality Rate
Mortality rate from upper gastrointestinal bleeding and from any etiology
30 days
Secondary Outcomes (6)
Rate of Reintervention
30 days
Rate of Recurrence
30 days
Rate of Readmission
30 days
Length of hospital stay
30 days
Costs
30 days
- +1 more secondary outcomes
Study Arms (1)
Patients with upper gastrointestinal bleeding
Patients with upper gastrointestinal bleeding undergoing endoscopic procedures at AdventHealth Hospitals in Central Florida
Interventions
Patients with upper gastrointestinal bleeding undergoing endoscopic therapy. Information regarding the need for interventional radiology procedures or surgical interventions will also be collected in patients in whom endoscopic therapy is not successful.
Eligibility Criteria
The population will come from patient who are undergoing endoscopic treatment for upper gastrointestinal bleeding at AdventHealth Hospitals.
You may qualify if:
- Patient is 18 years of age or greater
- Patient is undergoing endoscopic treatment for upper gastrointestinal bleeding
You may not qualify if:
- Under the age of 18
- Patient not undergoing endoscopic treatment for upper gastrointestinal bleeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AdventHealthlead
Study Sites (1)
Center for Interventional Endoscopy
Orlando, Florida, 32803, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shyam Varadarajulu, MD
AdventHealth Orlando
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2019
First Posted
December 26, 2019
Study Start
October 1, 2019
Primary Completion
January 31, 2021
Study Completion
January 31, 2021
Last Updated
February 17, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share